Takeda and Portal Instruments Announce Collaboration to Develop Needle-Free Drug Delivery Device

Portal Instruments and Takeda announced a collaboration to develop and commercialize Portal’s game changing needle-free drug delivery platform for potential use with Takeda’s investigational or approved biologic medicines.

Read More

A Letter From the CEO

Today we announced a groundbreaking partnership with Takeda. This is a significant milestone for Portal as it begins to validate our business model. I am thrilled about this achievement and would like to thank the whole team that has worked tirelessly to make this happen.

Read More

Boston Voyager Interviews Portal Instruments’ CEO Patrick Anquetil

Patrick Anquetil, CEO of Portal Instruments, was recently featured in Boston Voyager, an online magazine that focuses on local trends, start-ups and local businesses.

Read More

Portal Instruments Wins MedTech Breakthrough 2017 Award

Portal Instruments was awarded the MedTech Breakthrough 2017 Award for Best Overall Medical Device Product.

Read More

Portal Instruments’ CEO Patrick Anquetil interviewed by Medgadget

Portal Instruments’ CEO Patrick Anquetil was recently interviewed by Medgadget about Portal’s innovative needle-free drug delivery technology and its potential impact on existing treatment options of multiple chronic conditions.

Read More

Portal Instruments Appoints Wendy Dwyer as Chief Business Officer

Dwyer brings more than 18 years of business development experience to Portal Instruments. “Wendy is a proven leader with deep industry knowledge in forging strategic partnerships and a track record of getting things done and delivering results,” said Patrick Anquetil, CEO of Portal Instruments.

Read More

Drug Development and Delivery Showcases Portals’ Needle-Free Delivery Platform

Drug Development and Delivery recently published an article showcasing Portal Instruments’ transformative needle-free drug delivery platform and its partnership strategy.

Read More

Nature Features Portal Instruments in BioPharma Dealmakers’ Quarterly Magazine

Portal Instruments was recently re-featured in Nature’s BioPharma Dealmakers’ quarterly magazine, ahead of the BIO International 2017 event to be held in San Diego, CA over June 19-22, 2017.

Read More

Portal Instruments Marks Milestone, Publishing Results of Study in Peer-Reviewed Article in AAPS PharmSciTech

The clinical trial involving 40 healthy volunteers demonstrated that the reported pain associated with an injection using the Portal system was significantly lower than that reported from a subcutaneous injection with a 27G needle.

Read More

Portal Instruments Receives IS0 13485:2012 Certification

This certificate of registration from an independent organization ensures that Portal’s Quality Management System has been assessed and deemed to comply with the requirements of the IS0 13485:2012 standard within the scope of the following operations – namely the design, manufacture and distribution of hand-held needle-free injection devices for drug administration.

Read More